Home

Shree Ganesh Biotech India Ltd PE Ratio

Image

Shree Ganesh Biotech India Ltd

NSE: SHREEGANESHBIO

PE

19.6

Last updated on: Mar 19, 2025

Key Highlights

  • The P/E Ratio of Shree Ganesh Biotech India Ltd is 19.6 as of 19 Mar 15:30 PM .
  • The P/E Ratio of Shree Ganesh Biotech India Ltd changed from 1085 on March 2020 to 52.5 on March 2024 . This represents a CAGR of -45.43% over 5 years.
  • The Latest Trading Price of Shree Ganesh Biotech India Ltd is ₹ 0.98 as of 19 Mar 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Shree Ganesh Biotech India Ltd

No data available

Company Fundamentals for Shree Ganesh Biotech India Ltd

Image

Shree Ganesh Biotech India Ltd

NSE: SHREEGANESHBIO

Share Price

₹ 0.98

0.01 (1.03%)

stock direction

Last updated on: Mar 19, 2025

Market Price of Shree Ganesh Biotech India Ltd

1M

1Y

3Y

5Y

Monitoring Shree Ganesh Biotech India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
19 Mar 20250.98
18 Mar 20250.97
17 Mar 20250.94
13 Mar 20250.97
12 Mar 20250.99
11 Mar 20250.99
10 Mar 20250.99
07 Mar 20251
06 Mar 20250.99
05 Mar 20250.99

SWOT Analysis Of Shree Ganesh Biotech India Ltd

Strength

2

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Shree Ganesh Biotech India Ltd

Asset Value vs Market Value of Shree Ganesh Biotech India Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Shree Ganesh Biotech India Ltd39.07
Sun Pharmaceuticals Industries Ltd415913
Divis Laboratories Ltd154431
Cipla Ltd121021
Torrent Pharmaceuticals Ltd108046
Dr Reddys Laboratories Ltd97790

PE Ratio of Shree Ganesh Biotech India Ltd Explained

39.07

Market cap

1

Earnings

19.6X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Shree Ganesh Biotech India Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Shree Ganesh Biotech India Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Shree Ganesh Biotech India Ltd

No data available

* All values are in %

About Shree Ganesh Biotech India Ltd

  • Shree Ganesh Biotech India Limited was incorporated on September 2, 1982, as 'S.P. Commercial Co. Limited' under the Registrar of Companies, West Bengal.
  • The Company has got the Certificate of Commencement of Business on September 14, 1982 from the Registrar of Companies, West Bengal.
  • The Company was incorporated with an object to carry on the business of builders, Contractors and to deal in property and also to do investment and finance business. In 2010, pursuant to a Scheme of Amalgamation, Shree Ganesh Bio-Tech (India) Private Limited was merged with S.P. Commercial Co. Limited pursuant to the order of the Hon'ble High at Calcutta dated February 15, 2010.
  • The entire business of Shree Ganesh Bio-Tech (India) Private Limited consisting of trading and distribution of seeds were transferred to S.

Shree Ganesh Biotech India Ltd News Hub

Shree Ganesh Biotech India standalone net profit rises 60.00% in the June 2024 quarter

Net profit of Shree Ganesh Biotech India rose 60.00% to Rs 0.24 crore in the quarter ended June 2024

Read more

13 Aug 24

Shree Ganesh Biotech India to convene AGM

Shree Ganesh Biotech India announced that the Annual General Meeting (AGM) of the company will be he

Read more

16 Sept 24

Shree Ganesh Biotech India to conduct AGM

Shree Ganesh Biotech India announced that the Annual General Meeting (AGM) of the company will be he

Read more

14 Sept 24

Shree Ganesh Biotech India announces board meeting date

Shree Ganesh Biotech India will hold a meeting of the Board of Directors of the Company on 23 Octobe

Read more

17 Oct 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Shree Ganesh Biotech India Ltd

What is the current PE Ratio of Shree Ganesh Biotech India Ltd?

The Current PE Ratio of Shree Ganesh Biotech India Ltd is 19.6 as on 19 Mar 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 19 Mar 2025.

What was the PE Ratio of Shree Ganesh Biotech India Ltd last year?

The PE Ratio of Shree Ganesh Biotech India Ltd was 20.4 last year, now the PE ratio is 19.6, showing a year-on-year growth of -3.9%.

What does the PE Ratio of Shree Ganesh Biotech India Ltd indicate about its stock?

The PE Ratio of Shree Ganesh Biotech India Ltd is 19.6. This ratio indicates that investors are willing to pay 19.6 times the earnings per share for each share of Shree Ganesh Biotech India Ltd.

What is the PE Ratio Growth of Shree Ganesh Biotech India Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Shree Ganesh Biotech India Ltd grew by -3.9% whereas, the EPS ratio grew by 100.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions